Advertisement
News
Advertisement

CURE Foundation Selects Varian Medical Systems to Supply Radiotherapy Technology for Five New Cancer Centers

Fri, 10/29/2010 - 7:33am
Bio-Medicine.Org

PALO ALTO, Calif. and SPRINGFIELD, Va. Oct. 29 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR) today announced that CURE Foundation has placed an order for five Varian TrueBeam™ systems for stereotactic radiosurgery and radiation therapy.  

CURE Foundation, which placed the order in September, plans to install the TrueBeam systems in existing and new clinics on the U.S. East Coast during 2011.  

CURE Foundation was established in Springfield, VA in 2007 as a non-profit organization, with a goal to reduce the cost of healthcare and education and to establish cancer centers around the world.  

"We are excited to partner with Varian, the industry's leading provider of hardware and software for radiotherapy and radiosurgery," said Krish Suthanthiran, founder of CURE Foundation.  "We are working to establish a global network of cancer centers that offer patients high quality, affordable care, and Varian has the technology and products to help us achieve this goal."

"Varian is pleased to support CURE Foundation by supplying cutting-edge technologies for offering cancer patients high-precision radiotherapy treatment, along with the company's industry-leading software products for treatment planning," said Jeffrey Marcus, Varian vice-president for worldwide sales.  "We are excited about supporting CURE's goals of making high-quality cancer care more accessible around the world."

About Varian Medical Systems Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tu

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading